Related Experiment Video

Updated: Dec 19, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.3K

Ribosomal proteins as a possible tool for blocking SARS-COV 2 virus replication for a potential prospective treatment

Marian Rofeal1, Fady Abd El-Malek1

  • 1Department of Botany and Microbiology, Faculty of Science, Alexandria University, Egypt.

Medical Hypotheses
|June 6, 2020
PubMed

Insights

This study explores RNA-binding proteins (RPs) from bacteria and yeast for novel antiviral therapies against viruses like SARS-CoV-2. These RPs show potential in regulating viral replication and boosting host immunity for new treatments.

Area of Science:

  • Virology
  • Biochemistry
  • Immunology

Background:

  • Coronavirus disease (COVID-19), caused by SARS-CoV-2, has led to significant global health crises.
  • Viral replication relies on host factors, including RNA-binding proteins (RPs), which interact with viral mRNA for regulation and accumulation.
  • A small subset of RPs can trigger immune pathways, offering a defense against viral infections.

Discussion:

  • This research investigates RNA-binding proteins (RPs) from Bacillus species and yeast as a novel platform for antiviral therapy development.
  • The role of RPs in viral infections and their potential as therapeutic targets have been underexplored.
  • Antiviral strategies leveraging RPs could offer a promising avenue for future drug discovery.

Key Insights:

  • RNA-binding proteins (RPs) from microbial sources (Bacillus sp. and yeast) are proposed as a new basis for antiviral therapies.
  • Understanding RP interactions with viral components is crucial for regulating viral replication and infection.
  • RPs can play a role in host defense by activating immune responses against viruses.

Outlook:

  • Further research into RPs could unlock new therapeutic strategies against a range of viral diseases.
  • Exploring microbial RPs may lead to the development of broadly applicable antiviral agents.
  • This work highlights the potential of RPs as critical targets for next-generation antiviral treatments.
Keywords:
AntiviralCoronavirusRibosomal proteinsSARS-COV 2Viral translation

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-208:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

14.2K

Related Concept Videos

Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.1K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
13.2K
Ribozymes02:47

Ribozymes

3.2K
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
4.0K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
439